Treatment of cyclic neutropenia with granulocyte colony-stimulating factor

The New England Journal of Medicine
W P HammondD C Dale


Six patients with cyclic neutropenia were treated with recombinant human granulocyte colony-stimulating factor (G-CSF) for 3 to 15 months. All had a history of recurrent aphthous stomatitis, pharyngitis, lymphadenopathy, fever, and numerous infections during periods of neutropenia. Serial blood-cell counts, findings on bone marrow examination, and signs and symptoms were evaluated before and during the daily administration of G-CSF (3 to 10 micrograms per kilogram of body weight per day), either intravenously or subcutaneously. The kinetics of labeled autologous blood neutrophils and the migration of neutrophils to skin chambers were also measured. Recombinant human G-CSF increased the mean (+/- SEM) neutrophil counts from 717 +/- 171 per microliter to 9814 +/- 2198 per microliter (P = 0.009). In five of the six patients, the cycling of blood-cell counts continued, but the length of the period decreased from 21 to 14 days. The number of days of severe neutropenia was reduced (P = 0.002). Neutrophil turnover increased almost four-fold (P = 0.005), whereas neutrophil migration to a skin chamber was normal. G-CSF therapy reduced the frequency of oropharyngeal inflammation, fever, and infections in these patients. During the first ...Continue Reading


Jun 1, 1975·British Journal of Haematology·J B JonesR D Lange
Feb 9, 1978·The New England Journal of Medicine·D G WrightS M Wolff
Sep 1, 1988·Blood Reviews·D C Dale, W P Hammond
May 1, 1986·American Journal of Hematology·D B LensinkW P Hammond
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K KaushanskyJ W Adamson
Mar 1, 1974·The Journal of Clinical Investigation·P L WeidenR Storb
Dec 1, 1973·The Journal of Clinical Investigation·D GuerryS M Wolff
Aug 1, 1972·The Journal of Clinical Investigation·D C DaleS M Wolff
Feb 1, 1981·British Journal of Haematology·K J RoozendaalM L Boonzajer Flaes
Dec 1, 1957·A.M.A. Journal of Diseases of Children·A R PAGE, R A GOOD

❮ Previous
Next ❯


Dec 30, 1996·American Journal of Medical Genetics·S E PalmerD C Dale
Feb 1, 1992·American Journal of Hematology·T YujiriF Kurimoto
Jan 1, 1990·International Journal of Cell Cloning·D W Golde
Jul 1, 1991·International Journal of Cell Cloning·W LangeA Lindemann
Nov 1, 1991·Journal of Clinical Immunology·A K JunkerP C Rogers
Jan 1, 1994·Biotherapy·B A Kruskal, A B Ezekowitz
Jan 1, 1990·Biotherapy·F HerrmannR Mertelsmann
Jul 28, 2004·Journal of Mathematical Biology·Ivar Østby, Ragnar Winther
Mar 5, 2008·Journal of Mathematical Biology·Catherine Foley, Michael C Mackey
Oct 31, 2006·Zeitschrift für Rheumatologie·C Huemer, M Huemer
Dec 17, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·HyunKyung LeeHae Il Cheong
May 19, 2009·Clinical Reviews in Allergy & Immunology·Sumita Roy-Ghanta, Jordan S Orange
Jul 1, 1994·Immunopharmacology·M A Jagels, T E Hugli
Jan 1, 1994·International Journal of Antimicrobial Agents·J J Rusthoven
Feb 1, 1989·Current Opinion in Immunology·J P Revillard
Feb 1, 1991·Current Opinion in Immunology·M A VadasM J Elliot
Jul 10, 2003·Journal of Theoretical Biology·Samuel BernardMichael C Mackey
Mar 1, 1994·Baillière's Clinical Haematology·Z C Han, J P Caen
May 25, 2010·Nature Reviews. Cancer·Donald Metcalf
Jul 11, 2000·British Journal of Haematology·C ZeidlerK Welte
Feb 14, 2002·British Journal of Haematology·Thomas Lehrnbecher, Karl Welte
Apr 17, 2002·Seminars in Hematology·Laurence Boxer, David C Dale
Apr 17, 2002·Seminars in Hematology·David C DaleAndrew Aprikyan
Jul 9, 1992·The New England Journal of Medicine·G J Lieschke, A W Burgess
Mar 23, 2011·The Journal of Experimental Medicine·Mie HaraKeiichi Fukuda
Jun 1, 1997·Journal of Clinical Gastroenterology·F FataM S Cappell
Jul 1, 1996·The Pediatric Infectious Disease Journal·A S LauM C Yeung
Feb 16, 2002·Journal of Pediatric Hematology/oncology·D C DaleA G Aprikyan
Mar 7, 2002·Journal of Pediatric Hematology/oncology·A Banerjee, K M Shannon

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.